SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001558370-23-011727 from CytoDyn Inc. (CYDY)

CytoDyn Inc.
Date: July 6, 2023 · CIK: 0001175680 · Accession: 0001558370-23-011727

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-272815

Date
July 6, 2023
Author
Antonio Migliarese
Form
CORRESP
Company
CytoDyn Inc.

Letter

CYTODYN INC.

July 6, 2023

VIA EDGAR

Office of Life Sciences

Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, NE Washington, DC 20549

Attention: Tim Buchmiller

Re:CytoDyn Inc. Registration Statement on Form S-1 File No. 333-272815 Request for Acceleration

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, CytoDyn Inc. (the “Company”) hereby respectfully requests acceleration of the effectiveness of the Company’s Registration Statement on Form S-1 filed on June 21, 2023 (File No. 333-272815) (the “Registration Statement”) so that the Registration Statement shall become effective at 5 pm Eastern Time on July 10, 2023, or as soon as possible thereafter.

We would appreciate notification by telephone of the effective date of the Registration Statement and confirmation of such effectiveness in writing.

If you have any questions about the foregoing request, please contact our counsel, Mary Ann Frantz of Miller Nash LLP at (503) 205-2552, or the undersigned at (360) 980-8524. Thank you.

Very truly yours,
CYTODYN INC.

Show Raw Text
CORRESP
1
filename1.htm

​

CYTODYN INC.

July 6, 2023

VIA EDGAR

Office of Life Sciences

Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, NE
Washington, DC  20549

Attention:  Tim Buchmiller

​

Re:CytoDyn Inc.
Registration Statement on Form S-1
File No. 333-272815
Request for Acceleration

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, CytoDyn Inc. (the “Company”) hereby respectfully requests acceleration of the effectiveness of the Company’s Registration Statement on Form S-1 filed on June 21, 2023 (File No. 333-272815) (the “Registration Statement”) so that the Registration Statement shall become effective at 5 pm Eastern Time on July 10, 2023, or as soon as possible thereafter.

We would appreciate notification by telephone of the effective date of the Registration Statement and confirmation of such effectiveness in writing.

If you have any questions about the foregoing request, please contact our counsel, Mary Ann Frantz of Miller Nash LLP at (503) 205-2552, or the undersigned at (360) 980-8524.  Thank you.

Very truly yours,

CYTODYN INC.

​

By:  ​ ​/s/ Antonio Migliarese____

Antonio Migliarese
Chief Financial Officer

cc: Mary Ann Frantz, Miller Nash LLP

​